68 related articles for article (PubMed ID: 1669196)
1. [The effect of whole-body controlled hyperthermia on the energy resources of cancer patients].
Prokhorova VI; Zhavrid EA; Fradkin SZ; Rubanova VZ; Lappo SV; Tsyrus' TP
Vopr Onkol; 1991; 37(11-12):1050-4. PubMed ID: 1669196
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma.
Kettelhack C; Kraus T; Hupp T; Manner M; Schlag P
Eur J Surg Oncol; 1990 Aug; 16(4):370-5. PubMed ID: 2379595
[TBL] [Abstract][Full Text] [Related]
3. [Results and prospects for the clinical use of hyperthermia in oncology].
Savchenko NE; Zhakov IG; Fradkin SZ; Zhavrid ZA
Med Radiol (Mosk); 1987 Jan; 32(1):19-24. PubMed ID: 3807694
[TBL] [Abstract][Full Text] [Related]
4. [Effect of whole-body artificial hyperthermia on the immunity function in cancer patients].
Dzhaginian AI; Balliuzek FV
Vopr Onkol; 1984; 30(5):39-43. PubMed ID: 6730415
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body artificial controlled hyperthermia and hyperglycemia in the combined treatment of metastatic kidney cancer].
Mavrichev AS; Fradkin SZ; Zhavrid EA; Nodel'son SE; Rovbut' II
Urol Nefrol (Mosk); 1990; (3):48-52. PubMed ID: 2396340
[TBL] [Abstract][Full Text] [Related]
6. Local effect of hyperthermia for superficial and shallow-seated tumors.
Tsukiyama I; Kajiura Y; Ogino T; Akine Y; Egawa S
Radiat Med; 1990; 8(1):22-8. PubMed ID: 2374825
[TBL] [Abstract][Full Text] [Related]
7. A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2.
Rosenberg SA; Lotze MT; Muul LM; Leitman S; Chang AE; Vetto JT; Seipp CA; Simpson C
Surgery; 1986 Aug; 100(2):262-72. PubMed ID: 3526604
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of antioxidants and hyperthermia enhance bleomycin-induced cytotoxicity and lipid peroxidation in Chinese hamster ovary cells.
Khadir A; Verreault J; Averill DA
Arch Biochem Biophys; 1999 Oct; 370(2):163-75. PubMed ID: 10510274
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of systemic tolerance of 42.0 degrees C infrared-A whole-body hyperthermia in combination with hyperglycemia and hyperoxemia. A Phase-I study.
Steinhausen D; Mayer WK; von Ardenne M
Strahlenther Onkol; 1994 Jun; 170(6):322-34. PubMed ID: 8023241
[TBL] [Abstract][Full Text] [Related]
10. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
Haier J; Hohenberger P; Beck K; Schlag PM
Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
[TBL] [Abstract][Full Text] [Related]
11. History of regional chemotherapy for cancer of the extremities.
Ariyan CE; Brady MS
Int J Hyperthermia; 2008 May; 24(3):185-92. PubMed ID: 18392997
[TBL] [Abstract][Full Text] [Related]
12. Post-exercise substrate utilization after a high glucose vs. high fructose meal during negative energy balance in the obese.
Tittelbach TJ; Mattes RD; Gretebeck RJ
Obes Res; 2000 Oct; 8(7):496-505. PubMed ID: 11068955
[TBL] [Abstract][Full Text] [Related]
13. [Addition of hyperthermia. Heat potentiates cancer therapy].
Hegewisch-Becker S; Hossfeld DK
MMW Fortschr Med; 2001 Jun; 143(25):28-32. PubMed ID: 11468993
[TBL] [Abstract][Full Text] [Related]
14. [Whole-body hyperthermia and hyperglycemia in the combined treatment of rectal cancer].
Kulemin VV; Al'bitskiĭ VB; Kotomin SV; Varigin IuA
Med Radiol (Mosk); 1987 Jan; 32(1):50-2. PubMed ID: 3543598
[TBL] [Abstract][Full Text] [Related]
15. Principles and concept 1993 of the Systemic Cancer Multistep Therapy (sCMT). Extreme whole-body hyperthermia using the infrared-A technique IRATHERM 2000--selective thermosensitisation by hyperglycemia--circulatory back-up by adapted hyperoxemia.
von Ardenne M
Strahlenther Onkol; 1994 Oct; 170(10):581-9. PubMed ID: 7974169
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of brain metastases from solid tumours.
Cappuzzo F; Mazzoni F; Maestri A; Di Stefano A; Calandri C; Crino L
Forum (Genova); 2000; 10(2):137-48. PubMed ID: 10875975
[TBL] [Abstract][Full Text] [Related]
17. Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Eton O; Kharkevitch DD; Gianan MA; Ross MI; Itoh K; Pride MW; Donawho C; Buzaid AC; Mansfield PF; Lee JE; Legha SS; Plager C; Papadopoulos NE; Bedikian AY; Benjamin RS; Balch CM
Clin Cancer Res; 1998 Mar; 4(3):619-27. PubMed ID: 9533529
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermia and radiotherapy in the treatment of soft tissue sarcomas. First clinical experience.
Bistolfi F; Grillo Ruggieri F; Scielzo G
Panminerva Med; 1987; 29(2):105-13. PubMed ID: 3114700
[No Abstract] [Full Text] [Related]
19. Time-course changes in macronutrient metabolism induced by a nutritionally balanced low-calorie diet in obese women.
Labayen I; Diez N; Parra MD; Gónzalez A; Martínez JA
Int J Food Sci Nutr; 2004 Feb; 55(1):27-35. PubMed ID: 14630589
[TBL] [Abstract][Full Text] [Related]
20. Metabolic response of whole body and peripheral tissues to enteral nutrition in weight-losing cancer and noncancer patients.
Bennegård K; Edén E; Ekman L; Scherstén T; Lundholm K
Gastroenterology; 1983 Jul; 85(1):92-9. PubMed ID: 6406291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
